The WACC of Boill Healthcare Holdings Ltd (1246.HK) is 7.6%.
Range | Selected | |
Cost of equity | 5.2% - 30.5% | 17.85% |
Tax rate | 2.8% - 5.8% | 4.3% |
Cost of debt | 7.0% - 8.2% | 7.6% |
WACC | 6.7% - 8.5% | 7.6% |
Category | Low | High |
Long-term bond rate | 2.9% | 3.4% |
Equity market risk premium | 6.0% | 7.0% |
Adjusted beta | -2.21 | 1.6 |
Additional risk adjustments | 15.5% | 16.0% |
Cost of equity | 5.2% | 30.5% |
Tax rate | 2.8% | 5.8% |
Debt/Equity ratio | 29.53 | 29.53 |
Cost of debt | 7.0% | 8.2% |
After-tax WACC | 6.7% | 8.5% |
Selected WACC | 7.6% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
1246.HK | Boill Healthcare Holdings Ltd | 29.53 | -0.23 | -0.01 |
1746.HK | Man Shun Group (Holdings) Ltd | 0 | -0.31 | -0.31 |
1751.HK | Kingland Group Holdings Ltd | 0.19 | 0.27 | 0.23 |
2193.HK | Man King Holdings Ltd | 0.12 | 0.09 | 0.08 |
8023.HK | Kwong Man Kee Group Ltd | 0.08 | -0.44 | -0.41 |
8262.HK | Super Strong Holdings Ltd | 0.03 | -0.45 | -0.44 |
8316.HK | Quantong Holdings Ltd | 0.19 | -0.4 | -0.34 |
8366.HK | Zhejiang United Investment Holdings Group Ltd | 0.5 | 0.69 | 0.46 |
8445.HK | Noble Engineering Group Holdings Ltd | 0.01 | 0.05 | 0.05 |
8601.HK | Boltek Holdings Ltd | 0.04 | 0.28 | 0.27 |
Low | High | |
Unlevered beta | -0.13 | 0.06 |
Relevered beta | -3.79 | 1.9 |
Adjusted relevered beta | -2.21 | 1.6 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 1246.HK:
cost_of_equity (17.85%) = risk_free_rate (3.15%) + equity_risk_premium (6.50%) * adjusted_beta (-2.21) + risk_adjustments (15.75%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.